Drug Executive Collapses During Oval Office Press Conference
A press conference in the Oval Office was abruptly interrupted when a drug executive fainted while President Donald Trump was announcing a deal with drugmakers to lower obesity drug prices.
Details of the Incident
During a Thursday event, President Trump and representatives from Eli Lilly and Novo Nordisk discussed a new agreement to expand coverage and reduce costs for obesity treatments Zepbound and Wegovy. David Ricks, Eli Lilly's CEO, was speaking when he noticed someone collapsing and asked,
“Are you okay? Gordon, are you okay?”
Individuals Involved
- The man who collapsed was Gordon Findlay, the global brand director for Novo Nordisk.
- Dr. Mehmet Oz, Administrator for the Centers for Medicare & Medicaid Services, immediately assisted Findlay as he fell to his knees.
- Health and Human Services Secretary was also present during the incident.
Aftermath
Press members were quickly asked to leave the room. Approximately 30 minutes later, the conference resumed with President Trump providing an update on the executive’s condition.
“President Donald Trump looks on as Administrator for the Centers for Medicare & Medicaid Services Dr. Mehmet Oz and others help Gordon Findlay of Novo Nordisk.”
The press conference focused on efforts to reduce the cost of obesity drugs through cooperation with major pharmaceutical companies.
Author's summary: During a White House announcement on lowering obesity drug prices, Novo Nordisk's Gordon Findlay fainted, prompting immediate medical aid and a brief press interruption.
Would you like the summary to be more formal or casual?